Literature DB >> 10644516

Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts.

M V Panchenko1, H W Farber, J H Korn.   

Abstract

Heme oxygenase-1 (HO-1) catalyzes the rate-limiting step in heme catabolism and presumably is involved in cellular iron homeostasis. It is induced by a variety of cellular stresses, including oxygen deprivation and free radical-mediated stress. We examined induction of HO-1 mRNA in skin fibroblasts and investigated the mechanism by which it occurs. Hypoxia did not appear to act via induction of oxygen free radicals: induction of HO-1 was not sensitive to the free radical scavenger GSH or other antioxidants. Moreover, hypoxia did not increase steady-state levels of free radicals generated by fibroblasts. In contrast, HO-1 induction by the oxidants, H(2)O(2) and carbonyl cyanide m-chlorophenylhydrazone (CCCP) was significantly attenuated in the presence of free radical scavengers. This correlated with increased levels of free radical production in fibroblasts treated with these oxidants. Iron depletion by desferrioxamine mesylate, a specific iron complexon, completely inhibited hypoxic stimulation of HO-1 but did not attenuate the effect of H(2)O(2) and CCCP on HO-1 mRNA. Addition of Fe(2+), Fe(3+), or holo-transferrin to fibroblasts increased levels of HO-1 mRNA. Treatment of cells with hypoxia, but not H(2)O(2) or an exogenous source of iron, significantly increased the half-life of HO-1 mRNA. The data suggest hypoxia regulates HO-1 gene expression by a specific posttranscriptional mechanism: stabilization of mRNA. Hypoxia has previously been shown to increase fibroblast collagen synthesis and is thought to play a role in pathogenesis of systemic sclerosis (SSc). Skin fibroblasts isolated from patients with SSc demonstrated significantly stronger induction of HO-1 by hypoxia than did fibroblasts from normal controls. We hypothesize that exposure of SSc fibroblasts to hypoxic conditions leads to in vivo selective proliferation of cells that adapt to hypoxia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644516     DOI: 10.1152/ajpcell.2000.278.1.C92

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  23 in total

1.  Rickettsia rickettsii infection of cultured human endothelial cells induces heme oxygenase 1 expression.

Authors:  Elena Rydkina; Abha Sahni; David J Silverman; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 2.  The heme oxygenases: important regulators of pregnancy and preeclampsia.

Authors:  Eric M George; Junie P Warrington; Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-04       Impact factor: 3.619

3.  Regulation of heme oxygenase expression by alcohol, hypoxia and oxidative stress.

Authors:  Lisa Nicole Gerjevic; Sizhao Lu; Jonathan Pascal Chaky; Duygu Dee Harrison-Findik
Journal:  World J Biol Chem       Date:  2011-12-26

4.  Enhanced translation of heme oxygenase-2 preserves human endothelial cell viability during hypoxia.

Authors:  Jeff Z He; J J David Ho; Sheena Gingerich; David W Courtman; Philip A Marsden; Michael E Ward
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

5.  Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.

Authors:  Dhananjay K Kaul; Xiaoqin Zhang; Trisha Dasgupta; Mary E Fabry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

6.  Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura.

Authors:  Tao Chen; Zai-Pei Guo; Yu-Hong Zhang; Ying Gao; Hong-Jie Liu; Jing-Yi Li
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 2.631

7.  The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading.

Authors:  K J Livesey; V L C Wimhurst; K Carter; M Worwood; E Cadet; J Rochette; A G Roberts; J J Pointon; A T Merryweather-Clarke; M L Bassett; A-M Jouanolle; A Mosser; V David; J Poulton; K J H Robson
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

8.  Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis.

Authors:  Shihoko Okazaki; Fumihide Ogawa; Yohei Iwata; Toshihide Hara; Eiji Muroi; Kazuhiro Komura; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

9.  Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome.

Authors:  Lukas Andreas Heger; Mark Kerber; Marcus Hortmann; Samuel Robinson; Maximilian Mauler; Daniela Stallmann; Daniel Duerschmied; Christoph Bode; Christoph Hehrlein; Ingo Ahrens
Journal:  Acta Pharmacol Sin       Date:  2018-07-10       Impact factor: 6.150

Review 10.  New insights into intracellular locations and functions of heme oxygenase-1.

Authors:  Louise L Dunn; Robyn G Midwinter; Jun Ni; Hafizah A Hamid; Christopher R Parish; Roland Stocker
Journal:  Antioxid Redox Signal       Date:  2014-02-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.